Statistics

Total Visits

Views
Response to cabazitaxel in patients with metastatic castrationresistant prostate cancer (mCRPC) poorly responding to docetaxel70

Select a period of time:

Number of views in the range

Views
Response to cabazitaxel in patients with metastatic castrationresistant prostate cancer (mCRPC) poorly responding to docetaxel28

Views

Views
November 20250
December 20250
January 20260
February 20260
March 20262
April 20260
May 202626
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States17
Canada3
France2
Honduras1
Ireland1
Italy1
Kenya1
Paraguay1
South Africa1
 

Top cities views

Views
New York2
Jacksonville2
Angers1
Brooklyn1
Dublin1
Fairfield1
Fernando de la Mora1
Fort Erie1
Fox Lake1
Indian Trail1